These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2475234)

  • 1. [X-linked dyskeratosis congenita with aplastic anemia--genetic and hematologic studies].
    Lin TC; Lin CK; Lee JY; Chau WK; Wang SY
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jan; 43(1):57-62. PubMed ID: 2475234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked dyskeratosis congenita with pancytopenia.
    Gutman A; Frumkin A; Adam A; Bloch-Shtacher N; Rozenszajn LA
    Arch Dermatol; 1978 Nov; 114(11):1667-71. PubMed ID: 568915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyskeratosis congenita with hypoplastic anemia: a stem cell defect.
    Friedland M; Lutton JD; Spitzer R; Levere RD
    Am J Hematol; 1985 Sep; 20(1):85-7. PubMed ID: 4025322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyskeratosis congenita: unusual presenting features within a kindred.
    Forni GL; Melevendi C; Jappelli S; Rasore-Quartino A
    Pediatr Hematol Oncol; 1993; 10(2):145-9. PubMed ID: 8318369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
    Fogarty PF; Yamaguchi H; Wiestner A; Baerlocher GM; Sloand E; Zeng WS; Read EJ; Lansdorp PM; Young NS
    Lancet; 2003 Nov; 362(9396):1628-30. PubMed ID: 14630445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskeratosis congenita: two examples of this multisystem disorder.
    Womer R; Clark JE; Wood P; Sabio H; Kelly TE
    Pediatrics; 1983 Apr; 71(4):603-9. PubMed ID: 6601257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskeratosis congenita: clinical and genetic heterogeneity. Report of a new case and review of the literature.
    Drachtman RA; Alter BP
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):297-304. PubMed ID: 1456394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dyskeratosis congenita. Genetic hematologic-immunologic systemic disease with pancytopenia].
    Sölder B; Weiss M; Jäger A; Belohradsky BH
    Klin Padiatr; 1996; 208(6):344-9. PubMed ID: 9064376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow failure: a child is not just a small adult (but an adult can have a childhood disease).
    Alter BP
    Hematology Am Soc Hematol Educ Program; 2005; ():96-103. PubMed ID: 16304365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia, dyskeratosis congenita, and WT syndrome.
    Shahidi NT
    Am J Med Genet Suppl; 1987; 3():263-78. PubMed ID: 2453204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors.
    Găman A; Găman G; Bold A
    Rom J Morphol Embryol; 2009; 50(4):669-74. PubMed ID: 19942964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
    Polychronopoulou S; Koutroumba P
    Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskeratosis congenita.
    Vulliamy T; Dokal I
    Semin Hematol; 2006 Jul; 43(3):157-66. PubMed ID: 16822458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
    Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
    Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskeratosis congenita. Haematologic, cytogenetic, and dermatologic studies.
    Jacobs P; Saxe N; Gordon W; Nelson M
    Scand J Haematol; 1984 May; 32(5):461-8. PubMed ID: 6539499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere dysfunction and hematologic disorders.
    Paiva RM; Calado RT
    Prog Mol Biol Transl Sci; 2014; 125():133-57. PubMed ID: 24993701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of hematopoietic progenitor cells in patients with aplastic anemia after hematologic recovery.
    Issaragrisil S; Piankijagum A; Tang-Naitrisorana Y
    J Med Assoc Thai; 1989 Nov; 72(11):643-8. PubMed ID: 2635209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.